Terms: = Breast cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223 AND Treatment
53 results:
1. Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells.
Kopecka J; Barbanente A; Vitone D; Arnesano F; Margiotta N; Berchialla P; Niso M; Riganti C; Abate C
Pharmacol Rep; 2023 Dec; 75(6):1588-1596. PubMed ID: 37796435
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological Analysis and treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract] [Full Text] [Related]
3. Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer.
Yang M; Mahanty A; Jin C; Wong ANN; Yoo JS
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096527
[TBL] [Abstract] [Full Text] [Related]
4. Human fibroblasts facilitate the generation of iPSCs-derived mammary-like organoids.
Dai X; Wang X; Yang C; Huang M; Zhou Z; Qu Y; Cui X; Liu R; Chen C
Stem Cell Res Ther; 2022 Jul; 13(1):377. PubMed ID: 35902878
[TBL] [Abstract] [Full Text] [Related]
5. SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.
Lu Z; Mao W; Yang H; Santiago-O'Farrill JM; Rask PJ; Mondal J; Chen H; Ivan C; Liu X; Liu CG; Xi Y; Masuda K; Carrami EM; Chen M; Tang Y; Pang L; Lakomy DS; Calin GA; Liang H; Ahmed AA; Vankayalapati H; Bast RC
J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35642638
[TBL] [Abstract] [Full Text] [Related]
6. Ketogenic diet and cancer: fad or fabulous?
Mundi MS; Mohamed Elfadil O; Patel I; Patel J; Hurt RT
JPEN J Parenter Enteral Nutr; 2021 Nov; 45(S2):26-32. PubMed ID: 34897736
[TBL] [Abstract] [Full Text] [Related]
7. A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.
Fierheller CT; Guitton-Sert L; Alenezi WM; Revil T; Oros KK; Gao Y; Bedard K; Arcand SL; Serruya C; Behl S; Meunier L; Fleury H; Fewings E; Subramanian DN; Nadaf J; Bruce JP; Bell R; Provencher D; Foulkes WD; El Haffaf Z; Mes-Masson AM; Majewski J; Pugh TJ; Tischkowitz M; James PA; Campbell IG; Greenwood CMT; Ragoussis J; Masson JY; Tonin PN
Genome Med; 2021 Dec; 13(1):186. PubMed ID: 34861889
[TBL] [Abstract] [Full Text] [Related]
8. Optical Redox Imaging of treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative breast cancer Cells.
Podsednik A; Jiang J; Jacob A; Li LZ; Xu HN
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070254
[TBL] [Abstract] [Full Text] [Related]
9. Optical Redox Imaging Differentiates Triple-Negative breast cancer Subtypes.
Jiang J; Feng M; Jacob A; Li LZ; Xu HN
Adv Exp Med Biol; 2021; 1269():253-258. PubMed ID: 33966226
[TBL] [Abstract] [Full Text] [Related]
10. Homocysteine aggravates DNA damage by impairing the FA/Brca1 Pathway in NE4C murine neural stem cells.
Yan Y; Yin Y; Feng X; Chen Y; Shi J; Weng H; Wang D
Int J Med Sci; 2020; 17(16):2477-2486. PubMed ID: 33029090
[TBL] [Abstract] [Full Text] [Related]
11. Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India.
Ghosh J; Ganguly S; Mondal D; Pandey P; Dabkara D; Biswas B
JCO Glob Oncol; 2020 Jun; 6():844-851. PubMed ID: 32552110
[TBL] [Abstract] [Full Text] [Related]
12. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
Haynes B; Gajan A; Nangia-Makker P; Shekhar MP
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439
[TBL] [Abstract] [Full Text] [Related]
13. Outcomes of > 1300 Nipple-Sparing Mastectomies with Immediate Reconstruction: The Impact of Expanding Indications on Complications.
Young WA; Degnim AC; Hoskin TL; Jakub JW; Nguyen MD; Tran NV; Harless CA; Manrique OJ; Boughey JC; Hieken TJ
Ann Surg Oncol; 2019 Oct; 26(10):3115-3123. PubMed ID: 31342370
[TBL] [Abstract] [Full Text] [Related]
14. Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative breast cancer.
Tan AHY; Tu W; McCuaig R; Hardy K; Donovan T; Tsimbalyuk S; Forwood JK; Rao S
Front Immunol; 2019; 10():1351. PubMed ID: 31249575
[TBL] [Abstract] [Full Text] [Related]
15. Monitoring breast cancer Response to treatment Using Stokes Shift Spectroscopy of Blood Plasma.
Chithra K; Aruna P; Einstein G; Vijayaraghavan S; Ganesan S
J Fluoresc; 2019 May; 29(3):803-812. PubMed ID: 31187405
[TBL] [Abstract] [Full Text] [Related]
16. Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer.
Paula DP; do Brasil Costa VI; Jorge RV; Nobre FF
Support Care Cancer; 2020 Jan; 28(1):395-403. PubMed ID: 31056713
[TBL] [Abstract] [Full Text] [Related]
17. Induction of HRR genes and inhibition of DNMT1 is associated with anthracycline anti-tumor antibiotic-tolerant breast carcinoma cells.
Dasgupta H; Islam MS; Alam N; Roy A; Roychoudhury S; Panda CK
Mol Cell Biochem; 2019 Mar; 453(1-2):163-178. PubMed ID: 30178275
[TBL] [Abstract] [Full Text] [Related]
18. The Effects of the Training Program and Counseling Program Given to Women Who Underwent a Mastectomy and Spouses.
Çol BK; Kılıç D
J Cancer Educ; 2019 Dec; 34(6):1074-1082. PubMed ID: 30116989
[TBL] [Abstract] [Full Text] [Related]
19. Targeted mass spectrometry enables robust quantification of fancd2 mono-ubiquitination in response to DNA damage.
Whiteaker JR; Zhao L; Ivey RG; Sanchez-Bonilla M; Moore HD; Schoenherr RM; Yan P; Lin C; Shimamura A; Paulovich AG
DNA Repair (Amst); 2018 May; 65():47-53. PubMed ID: 29605812
[TBL] [Abstract] [Full Text] [Related]
20. Visualization of breast cancer Metabolism Using Multimodal Nonlinear Optical Microscopy of Cellular Lipids and Redox State.
Hou J; Williams J; Botvinick EL; Potma EO; Tromberg BJ
Cancer Res; 2018 May; 78(10):2503-2512. PubMed ID: 29535219
[TBL] [Abstract] [Full Text] [Related]
[Next]
